Drugging the Undruggable and beyond: Emerging precision oncology approaches to target acquired resistance to KRAS G12C and KRAS G12D inhibitors
- Ramesh Kale
- , Charudatt Samant*
- , Krishnadas Nandakumar
- , K. Sreedhara Ranganath Pai
- , Mandar Bhonde
*Corresponding author for this work
Research output: Contribution to journal › Review article › peer-review
7
Link opens in a new tab
Citations
(Scopus)